Auffret M - Search Results

1

Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review.

Facile A, Deliniere A, Auffret M, Vial T, Citterio-Quentin A, Chevalier P, Grenet G. Facile A, et al. Among authors: auffret m. Therapie. 2023 Oct 19:S0040-5957(23)00144-0. doi: 10.1016/j.therap.2023.10.002. Online ahead of print. Therapie. 2023. PMID: 37951784 No abstract available.

2

Clomiphene citrate and neural tube defects: a meta-analysis of controlled observational studies.

Auffret M, Cottin J, Vial T, Cucherat M. Auffret M, et al. BJOG. 2019 Aug;126(9):1127-1133. doi: 10.1111/1471-0528.15800. Epub 2019 May 23. BJOG. 2019. PMID: 31006176

3

Secukinumab-Induced Acute Autoimmune Hemolytic Anemia.

Rivas S, Vidon C, Vial T, Auffret M. Rivas S, et al. Among authors: auffret m. Ann Pharmacother. 2020 Sep;54(9):933-934. doi: 10.1177/1060028020907202. Epub 2020 Feb 17. Ann Pharmacother. 2020. PMID: 32062981 No abstract available.

4

Quantitative Prediction of Adverse Event Probability Due to Pharmacokinetic Interactions.

Tod M, Rodier T, Auffret M. Tod M, et al. Among authors: auffret m. Drug Saf. 2022 Jul;45(7):755-764. doi: 10.1007/s40264-022-01190-3. Epub 2022 Jun 23. Drug Saf. 2022. PMID: 35737292

5

What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.

Phokaewvarangkul O, Auffret M, Groppa S, Markovic V, Petrovic I, Bhidayasiri R. Phokaewvarangkul O, et al. Among authors: auffret m. J Neural Transm (Vienna). 2024 May 15. doi: 10.1007/s00702-024-02782-2. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 38747986 Review.

6

Correction: Electrophysiological signatures of anxiety in Parkinson's disease.

Yassine S, Almarouk S, Gschwandtner U, Auffret M, Fuhr P, Verin M, Hassan M. Yassine S, et al. Among authors: auffret m. Transl Psychiatry. 2024 Apr 16;14(1):192. doi: 10.1038/s41398-024-02908-w. Transl Psychiatry. 2024. PMID: 38627389 Free PMC article. No abstract available.

7

[Parkinson's disease: intrinsically palliative care].

Auffret M, Vérin M, Giffard M, Marguet D, Béreau M, Patat M. Auffret M, et al. Soins. 2024 Mar;69(883):53-57. doi: 10.1016/j.soin.2023.12.028. Epub 2024 Feb 16. Soins. 2024. PMID: 38453402 Free article. French.

8

Electrophysiological signatures of anxiety in Parkinson's disease.

Yassine S, Almarouk S, Gschwandtner U, Auffret M, Fuhr P, Verin M, Hassan M. Yassine S, et al. Among authors: auffret m. Transl Psychiatry. 2024 Jan 27;14(1):66. doi: 10.1038/s41398-024-02745-x. Transl Psychiatry. 2024. PMID: 38280864 Free PMC article.

9

Terminal Care in Parkinson's Disease: Real-Life Use of Continuous Subcutaneous Apomorphine Infusion to Improve Patient Comfort.

Béreau M, Giffard M, Clairet AL, Degenne G, Tatu L, Richfield E, Magnin E, Vérin M, Auffret M. Béreau M, et al. Among authors: auffret m. J Parkinsons Dis. 2024;14(1):209-219. doi: 10.3233/JPD-230201. J Parkinsons Dis. 2024. PMID: 38217611 Free PMC article.

10

Lacosamide use during breastfeeding: A case report and a literature review.

Cercos M, Seqat I, Facile A, Vial T, Auffret M. Cercos M, et al. Among authors: auffret m. Fundam Clin Pharmacol. 2024 Jun;38(3):575-578. doi: 10.1111/fcp.12971. Epub 2023 Dec 6. Fundam Clin Pharmacol. 2024. PMID: 38054544 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page